Background: Failure to induce oral tolerance may result in food allergy. Hydrolysed
| INTRODUCTION
Oral tolerance is the default response of the immune system to innocuous food proteins and is characterized by suppression of local and systemic immune responses to these proteins. 1 Failure to induce oral tolerance to food proteins may result in food allergy. While extensively hydrolysed and amino acid-based infant formulas are used to manage infants with cow's milk allergy, current international guidelines recommend the use of partially hydrolysed infant formula in infants with increased risk of developing allergic diseases, as a way to prevent the onset of food allergy, when breastfeeding is insufficient or not possible. 2, 3 In a recent clinical trial the preventive effect of a prebiotic supplemented partially hydrolysed whey-based infant formula (pHP) on the development of eczema in infants with increased risk of developing allergic diseases was investigated. 4 In this study, after 6 months of intervention, increased percentages of or -DRB5. 8 The presence of T cell epitopes in a pHP is essential for the induction of cow's milk protein-specific Tregs. Previously, we 9 and others 10 have identified T cell epitope-containing domains of β-lactoglobulin (BLG), the most abundant protein in whey and one of the major allergens in cow's milk. Amino acid (AA) #13-48 of mature BLG is of particular interest because we observed that synthetic peptides covering this region were able, in a preventive setting, to reduce the acute allergic skin response in a murine model for cow's milk allergy significantly. 9 Taken together, this region in BLG appears to be important for development of tolerance to whey antigens.
In order to determine the presence of specific sequences in biological samples, mass spectrometry (MS) is the method of choice as opposed to the more traditional techniques that are currently used to characterize protein hydrolysates. 11, 12 A recent development in MS, termed peptidomics, allows for the characterization of peptide sequences with great sensitivity and specificity and is rapidly gaining popularity. 13 This technique is capable of closing the gap between understanding the impact of sequence specificity in relation to the biological activity a protein hydrolysate might have.
In this study, we used MS to identify peptides in a pHP similar to that was investigated in the previously published clinical trial 4 aimed to prevent food allergy. Moreover, we showed that the identified peptides are presented by HLA-DRB1 to and recognized by T cells suggesting that they could serve as functional human T cell epitopes and play a role in the development of oral tolerance.
| MATERIAL AN D METHODS

| Hydrolysed infant formula
A mixture of acid whey concentrate and demineralised sweet whey is dissolved in water (purified by reversed osmosis) and afterwards hydrolysed under specific conditions. An established mixture of microbial endopeptidases and exopeptidases is used for hydrolysis.
Subsequently, the solution is spray dried. The resulting hydrolysate powder (pHP) is used as sole protein source in infant formulas for children at risk for cow's milk allergy. Ten different batches were analysed. All batches were produced by the same method and taken during a period of 2 months.
| Sample preparation for MS analysis
Samples were essentially prepared as described by Butré et al 14 with
the addition of a reduction and alkylation step. All chemicals were obtained from Sigma Aldrich (St. Louis, MO, United States). Briefly, the pHP batches were diluted to 0.5% (v/v) using 50 mmol/L ammonium bicarbonate followed by the reduction of peptides with 4 mmol/L DTT and alkylation with 8 mmol/L iodoacetamide. The mixture was cleared by centrifugation at 20 000 g for 10 minutes
and diluted to 0.1% (v/v) using 0.1 mol/L acetic acid.
| Liquid chromatographic-mass spectrometry (LC-MS) analysis
All samples were analysed by nanoflow liquid chromatography using an Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, CA, United States) coupled online to a LTQ Velos mass spectrometer (Thermo Fisher Scientific, Waltham, MA, United States). The liquid chromatography part of the system was operated in a setup essentially as described previously. 15 Full scan mass spectra (from m/z 300 to 1,200) were acquired at zoom scan rate after accumulation to a target value of 3,000. The five most intense ions at a threshold above 500 were selected for collision-induced at normalized collision energy of 35% after accumulation to a target value of 10,000.
| MS data analysis
All MS data were processed by Proteome Discoverer (version 2.1, Thermo Scientific). Peak lists were generated using a standard work- lihood of peptides to be true positives is described by their expect value ≤0.05. The false discovery rate was determined to be <1%.
| MHC Class II binding in silico assessment
The identified HLA-DR-restricted peptides were computed into the IEDB MHC Class II Binding Prediction software (http://tools.iedb.
org/mhcii/) in order to assess binding of discovered peptides to the selected HLA-DRB1 alleles, as described. 18, 19 The default IEDB recommended prediction method was selected. For each peptide sequence (15 mers long), a percentile rank was generated by comparing the peptide's score against the scores of five million random 15 mers selected from the Swiss-Prot database. A lower percentile rank indicates a higher affinity of peptide binding to a particular MHC class II allele, in which the IEDB recommends to make a selection based on a consensus percentile rank of the top 10%. In order to be more stringent with the in silico assessment, we made an arbitrary selection based on a consensus percentile rank of the top 3%.
| T cell proliferation assay
Synthetic peptides (JPT Technologies, Berlin, Germany) identical to the peptides identified in pHP were dissolved in dimethylsulfoxide (Sigma Aldrich) at a concentration of 5.3 mmol/L. The peptides were tested on cow's milk protein-specific T cell lines (TCLs) from three infant donors, aged <1 year, 7.5 months and 6 years old.
These TCLs were generated previously and have been shown to recognize epitopes in the region of interest (AA#13-48 of mature BLG). 9 Proliferation was determined as described previously. 20 Stimulation indexes (SIs, ratio between proliferation of allergen/peptide-stimulated and non-stimulated T cells) were calculated and a SI ≥2 was considered positive.
| RESULTS
| pHP characterization by MS
To determine the peptide sequences present in the specific pHP, 10 different commercial batches were analysed by LC-MS, which is shown schematically in Table S1 ). Six of them were identified consistently in all 10 batches. Unambiguous peptide identifications were Figure S1 where the fragmentation spectra of the experimental and synthetic peptide show excellent correlation. In this way, the identity of the six peptides found in all 10 batches ( Figure 1 ) was confirmed.
| In vitro identification of HLA-DR-restricted peptides
The ProPresent ® antigen presentation assay was performed on 12 healthy donors with known HLA-DRB1 types, in order to identify potential T cell epitopes within the pHP. By focusing on BLG-derived sequences, 15 relevant peptides with an expect value ≤ 0.05 were identified within five donor samples (See Supporting Information As shown in Table 2 , with an arbitrary threshold of percentile rank set at <3% (ie, top 3% high binders), fragments of DIQ…DIS (AA#11-30) were predicted to have high affinity to bind to five HLA-DRB1 alleles, ie, DRB1*01:01, *04:01, *04:04, *04:05 and *09:01.
In contrast, it was estimated that only one fragment of AMA…APL (AA#23-39) would bind to HLA-DRB1*07:01 with high affinity.
Taken together, these findings suggest that fragments from AA#11-30 had a higher likelihood to be presented as T cell epitopes than the ones from AA#23-39. Moreover, the data suggest that several F I G U R E 1 Schematic overview of the applied LC-MS methodology. A specific partially hydrolysed infant formula (A) was analysed by mass spectrometry (B) and peptides were identified through database searching (C). In total six peptides were identified consistently in all 10 batches that mapped to BLG (structure is shown in pink and blue fonts) and located to the region of interest (shown in blue font) (D) 
| Identified peptides induced proliferation of cow's milk protein-specific T cells
To confirm that the peptides identified in pHP were recognized by T cells, synthetic peptides identical to the identified peptides were tested on cow's milk protein-specific human TCLs. As there was a distinct overlap between the identified peptides, we tested five peptides (Supporting Information Table S1 , italic sequences) that were identified in all batches and differed by more than 1AA from each other. All tested peptides were able to induce proliferation and showed a concentration-dependent effect (Figure 2 ). However, each donor showed a different recognition pattern which was confirmed by the in silico prediction data (Supporting Information Table S5 ). All five peptides induced proliferation of TCL B suggesting that this TCL recognizes either the overlapping part of the peptides (AA#11-27) or multiple T cell epitopes in this region. TCL A showed a proliferative response after stimulation with four of the five tested peptides. As peptide LIV…AAS (AA#1-27) was not able to induce proliferation, while peptide LIV…SLL (AA#1-32) did, the region containing AA#28-32 (DISLL) was essential for the response of TCL A. Unexpectedly, TCL C recognized peptide LIV…AAS (AA#1-27), while the longer peptide containing the same sequence with five additional AAs, LIV…SLL (AA#1-32), was not able to induce a proliferative response indicating that the structure of the peptide is essential for its ability to stimulate T cell proliferation.
| DISCUSSION
In this study, we analysed a specific pHP to detect the presence of BLG-derived peptides of interest. Moreover, we have investigated the ability of human MHC class II molecules to present these specific BLG-derived peptides and proved that these peptides were functional indeed.
Currently, hydrolysed infant formulas are characterized mainly by methods that provide only information on the degree of hydrolysis and the peptide weight distribution. 11, 12 Although important and informative, these characterizations do not provide any information about the sequence and specific activity of the peptides present in the formula. Especially, with the current understanding of sequence specificity in relation to immune modulation, structural information is crucial to understand the overall biological activity of a hydrolysed infant formula. The advantage of the applied methodology is that exact peptide sequences are identified which is important since many factors influence the generation of peptide sequences such as the protein source, used enzymes, hydrolysis time and temperature.
However, depending on the applied sample preparation and/or analytical method, physicochemical properties of certain peptides may prohibit straightforward detection. Therefore, some peptides that are present in the sample might not be detected.
Six peptides that originated from a region in BLG known to contain T cell epitopes were identified in ten different production batches of a specific pHP. Only two studies investigated the peptide profile of pHP previously. 21, 22 Although these studies focused on bioactive peptides in general and not specifically on T cell epitopes, none of the peptides we identified were found in these previously tested products. Català-Clariana et al 22 identified a related, but not identical peptide of 9AAs (AA#32-40) in our region of interest (AA#13-48). In addition to the profiles of these pHPs, the peptide profile of a non-commercial BLG-based hydrolysate has been determined. 23 Also in this hydrolysate, two peptides (AA#21-40 and AA#25-40) that overlap with our region of interest were identified but none of these peptides had a similar sequence as found in our study. In two of the three previous studies, a hydrolysate from a different manufacturer was investigated. 21, 23 The main reason for different peptide sequences found could be the manufacturing processes as indicated above. This is further corroborated by a recent study in which extensively hydrolysed infant formulas from T A B L E 2 In silico assessment on potential peptide-HLA-DRB1 complexes of two identified BLG-derived peptides with percentile rank <3% Subsequent to the peptide identification process, we determined whether and which peptides within the tested pHP were presented by HLA-DRB1 molecules. The HLA-DRB1 was prioritized in this study due to the facts that the HLA-DR molecule is the most predominant human MHC class II isotype (>90%) 25 and that HLA-DRB1 gene locus is polymorphic, while HLA-DRA1 gene locus is monomorphic (ie, HLA-DRB1 genotype determines the whole HLA-DR molecule). 26 Furthermore, HLA-DRB1 allele is expressed five times higher than its paralogs (HLA-DRB3, -DRB4 or -DRB5) and is present in all individuals. 8 Two sequence groups (AA#11-30 and AA#23-39) were identified to bind to several HLA-DRB1 molecules. As most donors were heterozygous for HLA-DRB1, the sequences were subjected to the MHC class II binding algorithm to determine which of the two molecules was able to present the peptides with high affinity (top 3%). Importantly, several in silico assessments confirmed the in vitro 10 Moreover, we only investigated peptides detected in a specific region of interest thus far, whereas previous studies have shown that other regions of BLG also contain T cell epitopes. 9, 10 Together this suggests that the MHC class II coverage on presentation of BLG-derived peptides present in the tested pHP might be broader than our current finding.
HLA-DRB1 allele
To confirm that the peptides identified in pHP were recognized
by T cells, we tested them on cow's milk protein-specific TCLs and
showed that all five peptides tested were indeed able to induce pro- Table S5 ).
For TCL C, all known HLA-DRB*03 and *13 alleles were tested in the algorithm as the genotyping was incomplete and the results indicated that some of the HLA-DRB*13 alleles were able to present fragments of the tested peptides. However, there are too many uncertainties to make convincing conclusions from these data. TCL
A recognizes an overlapping fragment from two tested peptides, ie, TMK…DAQ (AA#6-35) and DIQ…RVY (AA#11-42), which is supported by the algorithm data. In contrast, this TCL was able to recognize two additional tested peptides that were not predicted by the algorithm, namely LIV…SLL and TMK…SLL. However, these proliferative responses were observed upon stimulation with the mentioned peptides at the highest concentration only (Figure 2 ). One possible explanation is that since our data were primarily based on HLA-DRB1 alleles, other MHC class II molecules (eg, HLA-DRB3/4/5 or HLA-DP or HLA-DQ) could present those tested peptides to T cells and further stimulate them. Alternatively, a lower binding affinity could explain why the peptides were not identified by the algorithm and why stimulation occurs only at the highest concentration.
For instance, the prediction results for TCL A show recognition of an overlapping fragment from the two peptides in question, LIV…SLL and TMK…SLL, but at a percentile rank of 4.4% which was just above the threshold of 3% and as a result was not considered. Even though the affinity of these peptides is lower they could induce stimulation when the concentration of the peptide is high enough.
Further research should confirm this. [32] [33] [34] This suggests that peptides within the tested pHP can be absorbed after oral intake, followed by antigen capture and presentation by intestinal CD103 + DCs and subsequently culminated in generation of functional Tregs. Previously, we have shown in a murine cow's milk allergy model that administration of the same pHP prior to induction of cow's milk allergy increased the percentage of Tregs in the mesenteric lymph nodes leading to a significantly reduced acute allergic skin response to whey. 35 Moreover, a similar result was seen when synthetic peptides were used for this preventive treatment 9 indicating that the peptides reached the right compartments in the intestine for inducing oral tolerance.
It is imperative that for the development of oral tolerance, T cell epitopes within the tested pHP need to be presented under the right circumstances. As indicated before, in addition to TCR activation, costimulation and cytokine signalling play an important role in the generation of Tregs. 6 For example, retinoic acid and TGF-β are required for the induction of Tregs. Previously, we have shown that pre-or synbiotics may play an important role in creating the right environment for this predisposition towards Tregs. 9, [35] [36] [37] The preventive effect of both pHP and synthetic peptides was strengthened in combination with a pre-or synbiotic diet in a murine model for cow's milk allergy. Moreover, clinical evidence for the support of oral tolerance was provided by increased levels of plasmacytoid DCs and
Tregs upon nutritional intervention with the pHP supplemented with prebiotics. 4 In conclusion, this study demonstrated for the first time that a specific pHP contains functional human T cell epitopes. We suggest that this pHP under the right circumstances may stimulate the development of oral tolerance to whey and thereby contribute to allergy prevention. 
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